These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 27672294)

  • 1. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer.
    Huang F; Wang BR; Wu YQ; Wang FC; Zhang J; Wang YG
    World J Gastroenterol; 2016 Sep; 22(35):7999-8009. PubMed ID: 27672294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting pediatric cancer stem cells with oncolytic virotherapy.
    Friedman GK; Cassady KA; Beierle EA; Markert JM; Gillespie GY
    Pediatr Res; 2012 Apr; 71(4 Pt 2):500-10. PubMed ID: 22430386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncolytic virotherapy: new strategies in oncology].
    Fábián Z
    Orv Hetil; 2007 Oct; 148(43):2019-26. PubMed ID: 17947194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oncolytic viruses for genetic therapy of gastrointestinal tumors].
    Bitzer M; Lauer UM
    Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical development directions in oncolytic viral therapy.
    Eager RM; Nemunaitis J
    Cancer Gene Ther; 2011 May; 18(5):305-17. PubMed ID: 21436867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United virus: the oncolytic tag-team against cancer!
    Le Boeuf F; Bell JC
    Cytokine Growth Factor Rev; 2010; 21(2-3):205-11. PubMed ID: 20227326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between oncolytic viruses and autophagy in cancer therapy.
    Jin KT; Tao XH; Fan YB; Wang SB
    Biomed Pharmacother; 2021 Feb; 134():110932. PubMed ID: 33370632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GP73-regulated oncolytic adenoviruses possess potent killing effect on human liver cancer stem-like cells.
    Zhang X; Meng S; Zhang R; Ma B; Liu T; Yang Y; Xie W; Liu X; Huang F; Liu T; Zhou X; Liu X; Wang Y
    Oncotarget; 2016 May; 7(20):29346-58. PubMed ID: 27121064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting cancer-initiating cells with oncolytic viruses.
    Cripe TP; Wang PY; Marcato P; Mahller YY; Lee PW
    Mol Ther; 2009 Oct; 17(10):1677-82. PubMed ID: 19672244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer.
    Fujiwara T; Shirakawa Y; Kagawa S
    Expert Rev Anticancer Ther; 2011 Apr; 11(4):525-32. PubMed ID: 21504319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic viral therapy for pancreatic cancer.
    Rahal A; Musher B
    J Surg Oncol; 2017 Jul; 116(1):94-103. PubMed ID: 28407327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccinia virus, a promising new therapeutic agent for pancreatic cancer.
    Al Yaghchi C; Zhang Z; Alusi G; Lemoine NR; Wang Y
    Immunotherapy; 2015; 7(12):1249-58. PubMed ID: 26595180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
    Crupi MJF; Bell JC; Singaravelu R
    Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus, Oncolytic Virus and Human Prostate Cancer.
    Liu GB; Zhao L; Zhang L; Zhao KN
    Curr Cancer Drug Targets; 2017; 17(6):522-533. PubMed ID: 27993115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.
    Bach P; Abel T; Hoffmann C; Gal Z; Braun G; Voelker I; Ball CR; Johnston IC; Lauer UM; Herold-Mende C; Mühlebach MD; Glimm H; Buchholz CJ
    Cancer Res; 2013 Jan; 73(2):865-74. PubMed ID: 23293278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant Immunomodulating Lentogenic or Mesogenic Oncolytic Newcastle Disease Virus for Treatment of Pancreatic Adenocarcinoma.
    Buijs P; van Nieuwkoop S; Vaes V; Fouchier R; van Eijck C; van den Hoogen B
    Viruses; 2015 Jun; 7(6):2980-98. PubMed ID: 26110582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic reovirus effectively targets breast cancer stem cells.
    Marcato P; Dean CA; Giacomantonio CA; Lee PW
    Mol Ther; 2009 Jun; 17(6):972-9. PubMed ID: 19293772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer.
    Martin NT; Roy DG; Workenhe ST; van den Wollenberg DJM; Hoeben RC; Mossman KL; Bell JC; Bourgeois-Daigneault MC
    Sci Rep; 2019 Feb; 9(1):1865. PubMed ID: 30755678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy.
    Kasuya H; Nishiyama Y; Nomoto S; Goshima F; Takeda S; Watanabe I; Nomura N; Shikano T; Fujii T; Kanazumi N; Nakao A
    Cancer Gene Ther; 2007 Jun; 14(6):533-42. PubMed ID: 17415379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus combinations and chemotherapy for the treatment of human cancers.
    Kumar S; Gao L; Yeagy B; Reid T
    Curr Opin Mol Ther; 2008 Aug; 10(4):371-9. PubMed ID: 18683102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.